Nalaganje...

Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines

Invariant natural killer T (iNKT) cells have the capacity to amplify adaptive immune responses by licensing antigen-presenting cells. A simple vaccine consisting of whole tumor cells pulsed with an iNKT-cell agonist efficiently delivers antigens plus adjuvants to endogenous dendritic cells and has p...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Hunn, Martin K., Hermans, Ian F.
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3654595/
https://ncbi.nlm.nih.gov/pubmed/23734325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.23789
Oznake: Označite
Brez oznak, prvi označite!